Inflammatory Bowel Diseases

Copyright © 2013 Crohn's & Colitis Foundation of America, Inc.

Cover image for Vol. 18 Issue 8

August 2012

Volume 18, Issue 8

Pages 1399–1591, E1592–E1600

  1. Original Basic Science Articles

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Basic Science Reviews
    5. Clinical Reviews
    6. Selected Summaries
    7. Erratum
    8. Letters to the Editor
    1. Genes associated with intestinal permeability in ulcerative colitis: Changes in expression following infliximab therapy (pages 1399–1410)

      Gary Toedter, Katherine Li, Sarah Sague, Keying Ma, Colleen Marano, Michael Macoritto, Jennifer Park, Renée Deehan, Andrea Matthews, Gary D. Wu, James D. Lewis, Ingrid Arijs, Paul Rutgeerts and Frédéric Baribaud

      Article first published online: 4 JAN 2012 | DOI: 10.1002/ibd.22853

    2. Temporal genome expression profile analysis during t-cell-mediated colitis: Identification of novel targets and pathways (pages 1411–1423)

      Kai Fang, Songlin Zhang, John Glawe, Matthew B. Grisham and Christopher G. Kevil

      Article first published online: 16 DEC 2011 | DOI: 10.1002/ibd.22842

    3. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics (pages 1424–1433)

      Rob Mariman, Bas Kremer, Marjan van Erk, Tonny Lagerweij, Frits Koning and Lex Nagelkerken

      Article first published online: 11 DEC 2011 | DOI: 10.1002/ibd.22849

    4. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1−/−;Nod2−/− Mice (pages 1434–1446)

      Jane M.M. Natividad, Valerie Petit, Xianxi Huang, Giada de Palma, Jennifer Jury, Yolanda Sanz, Dana Philpott, Clara L. Garcia Rodenas, Kathy D. McCoy and Elena F. Verdu

      Article first published online: 11 DEC 2011 | DOI: 10.1002/ibd.22848

    5. Heligmosomoides polygyrus abrogates antigen-specific gut injury in a murine model of inflammatory bowel disease (pages 1447–1455)

      John Leung, Long Hang, Arthur Blum, Tommy Setiawan, Korynn Stoyanoff and Joel Weinstock

      Article first published online: 4 JAN 2012 | DOI: 10.1002/ibd.22858

    6. P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells (pages 1456–1469)

      Djordje M. Grbic, Émilie Degagn, Jean-François Larrive, Maude S. Bilodeau, Valrie Vinette, Guillaume Arguin, Jana Stankova and Fernand-Pierre Gendron

      Article first published online: 17 NOV 2011 | DOI: 10.1002/ibd.21931

  2. Original Clinical Articles

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Basic Science Reviews
    5. Clinical Reviews
    6. Selected Summaries
    7. Erratum
    8. Letters to the Editor
    1. Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study (pages 1470–1479)

      Asit Parikh, Timothy Leach, Tim Wyant, Catherine Scholz, Serap Sankoh, Diane R. Mould, Terry Ponich, Irving Fox and Brian G. Feagan

      Article first published online: 6 DEC 2011 | DOI: 10.1002/ibd.21896

    2. Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease (pages 1480–1487)

      Toshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, Satoshi Motoya, Hiroaki Ito, Kenta Motegi, Yoshitaka Kinouchi, Masakazu Takazoe, Yasuo Suzuki, Takayuki Matsumoto, Kazuhiko Kawakami, Takayuki Matsumoto, Ichiro Hirata, Shinji Tanaka, Toshifumi Ashida and Toshiyuki Matsui

      Article first published online: 10 OCT 2011 | DOI: 10.1002/ibd.21886

    3. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: A case series (pages 1488–1492)

      Imad Absah and William A. Faubion Jr

      Article first published online: 31 AUG 2011 | DOI: 10.1002/ibd.21885

    4. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease (pages 1493–1497)

      Ron Shaoul, Marlgozata Sladek, Dan Turner, Anders Paeregaard, Gabor Veres, Gigi Veereman Wauters, Johanna Escher, Jorge Amil Dias, Paolo Lionetti, Annamaria Staino, Kaija Leena Kolho, Lissy de Ridder, Federica Nuti, Salvatore Cucchiara, Orit Sheva and Arie Levine, and the ESPGHAN Porto IBD Group

      Article first published online: 24 JAN 2012 | DOI: 10.1002/ibd.21875

    5. Direct medical cost of managing IBD patients: A Canadian population-based study (pages 1498–1508)

      Charles N. Bernstein, Teresa Longobardi, Greg Finlayson and James F. Blanchard

      Article first published online: 22 NOV 2011 | DOI: 10.1002/ibd.21878

    6. Efficacy of different therapeutic options for spontaneous abdominal abscesses in Crohn's disease: Are antibiotics enough? (pages 1509–1514)

      Fernando Bermejo, Elena Garrido, María Chaparro, Jordi Gordillo, Miriam Mañosa, Alicia Algaba, Antonio López-Sanromán, Javier P. Gisbert, Esther García-Planella, Iván Guerra and Eugeni Domènech

      Article first published online: 29 AUG 2011 | DOI: 10.1002/ibd.21865

    7. Ovarian reserve in young women of reproductive age with Crohn's disease (pages 1515–1522)

      Thomas Fréour, Charline Miossec, Kalyane Bach-Ngohou, Thomas Dejoie, Mathurin Flamant, Olivier Maillard, Marc G. Denis, Paul Barriere, Stanislas Bruley des Varannes, Arnaud Bourreille and Damien Masson

      Article first published online: 20 SEP 2011 | DOI: 10.1002/ibd.21872

    8. Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL) (pages 1523–1530)

      Stephan R. Vavricka, Nicoletta Bentele, Michael Scharl, Gerhard Rogler, Jonas Zeitz, Pascal Frei, Alex Straumann, Janek Binek, Alain M. Schoepfer and Michael Fried, for the Swiss IBDnet and the Swiss IBD Cohort Study Group

      Article first published online: 10 OCT 2011 | DOI: 10.1002/ibd.21888

    9. You have free access to this content
      Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer (pages 1531–1539)

      Sonia Friedman, Adam S. Cheifetz, Francis A. Farraye, Peter A. Banks, Frederick L. Makrauer, Robert Burakoff, Barbara Farmer, Leanne N. Torgersen and Kelly E. Wahl

      Article first published online: 16 SEP 2011 | DOI: 10.1002/ibd.21861

    10. Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: Results from the IBSEN study (pages 1540–1549)

      Marte L. Hoivik, Bjorn Moum, Inger C. Solberg, Milada Cvancarova, Ole Hoie, Morten H. Vatn and Tomm Bernklev, , for the IBSEN Study Group

      Article first published online: 20 SEP 2011 | DOI: 10.1002/ibd.21863

  3. Basic Science Reviews

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Basic Science Reviews
    5. Clinical Reviews
    6. Selected Summaries
    7. Erratum
    8. Letters to the Editor
    1. Adipose tissue and inflammatory bowel disease pathogenesis (pages 1550–1557)

      Christopher Fink, Iordanes Karagiannides, Kyriaki Bakirtzi and Charalabos Pothoulakis

      Article first published online: 8 MAR 2012 | DOI: 10.1002/ibd.22893

    2. You have free access to this content
      Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases (pages 1558–1565)

      Trenton R. Schoeb and Daniel C. Bullard

      Article first published online: 31 JAN 2012 | DOI: 10.1002/ibd.22892

  4. Clinical Reviews

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Basic Science Reviews
    5. Clinical Reviews
    6. Selected Summaries
    7. Erratum
    8. Letters to the Editor
    1. Mortality from inflammatory bowel diseases (pages 1566–1572)

      Christian P. Selinger and Rupert W. Leong

      Article first published online: 24 JAN 2012 | DOI: 10.1002/ibd.22871

    2. An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation (pages 1573–1581)

      Antonina A. Mikocka-Walus, Deborah Turnbull, Gerald Holtmann and Jane M. Andrews

      Article first published online: 16 DEC 2011 | DOI: 10.1002/ibd.22850

    3. Integrated models of care in managing inflammatory bowel disease: A discussion (pages 1582–1587)

      Antonina A. Mikocka-Walus, Jane M. Andrews, Charles N. Bernstein, Lesley A. Graff, John R. Walker, Antonino Spinelli, Silvio Danese, C. Janneke van der Woude, James Goodhand, David Rampton and Gabriele Moser

      Article first published online: 12 JAN 2012 | DOI: 10.1002/ibd.22877

  5. Selected Summaries

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Basic Science Reviews
    5. Clinical Reviews
    6. Selected Summaries
    7. Erratum
    8. Letters to the Editor
    1. Postoperative morbidity and perioperative anti-TNF treatment: Should we blame the drugs? (page 1588)

      A. D'Hoore and A. Wolthuis

      Article first published online: 11 JAN 2012 | DOI: 10.1002/ibd.22867

    2. SWITCHing anti-TNF for nonclinical reasons? Think again! (pages 1589–1590)

      Garret Cullen

      Article first published online: 4 JAN 2012 | DOI: 10.1002/ibd.22868

  6. Erratum

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Basic Science Reviews
    5. Clinical Reviews
    6. Selected Summaries
    7. Erratum
    8. Letters to the Editor
    1. You have free access to this content
      Erratum: Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: Evidence of gene-gene interactions (page 1591)

      Article first published online: 16 JUL 2012 | DOI: 10.1002/ibd.23056

      This article corrects:

      Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: Evidence of gene–gene interactions

      Vol. 14, Issue 11, 1528–1541, Article first published online: 2 JUN 2008

  7. Letters to the Editor

    1. Top of page
    2. Original Basic Science Articles
    3. Original Clinical Articles
    4. Basic Science Reviews
    5. Clinical Reviews
    6. Selected Summaries
    7. Erratum
    8. Letters to the Editor
    1. Delayed hypersensitivity reaction with infliximab: Unusual to occur after initial dose (pages E1592–E1593)

      Mazer R. Ally, John D. Betteridge and Ganesh R. Veerappan

      Article first published online: 9 JAN 2012 | DOI: 10.1002/ibd.21909

    2. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: Don't forget the role of cyclosporin (pages E1594–E1595)

      Emanuele Sinagra, Ambrogio Orlando, Sara Renna, Marcello Maida and Mario Cottone

      Article first published online: 29 OCT 2011 | DOI: 10.1002/ibd.21915

    3. Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy (pages E1596–E1597)

      Christopher J. Smart, Adam Gibb and John Radford

      Article first published online: 31 JAN 2012 | DOI: 10.1002/ibd.21918

    4. Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab is associated with a profound long-lasting depletion of Foxp3+ regulatory T cells: A mechanistic explanation for ipilimumab-induced severe enterocolitis? (pages E1598–E1600)

      S. Nancey, G. Boschetti, E. Cotte, K. Ruel, T. Almeras, M. Chauvenet, K. Stroeymeyt, D. Moussata, D. Kaiserlian and B. Flourié

      Article first published online: 8 NOV 2011 | DOI: 10.1002/ibd.21927

SEARCH

SEARCH BY CITATION